This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Cencora (COR), UnitedHealth (UNH) and Humana (HUM)

Tipranks - Tipranks - Thu Jun 25, 4:52AM CDT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cencora (COR), UnitedHealth (UNH) and Humana (HUM).

TipRanks' Prime Week Sale - 70% Off

Cencora (COR)

Bank of America Securities analyst Allen Lutz maintained a Hold rating on Cencora today and set a price target of $285.00. The company’s shares closed last Tuesday at $281.10.

According to TipRanks.com, Lutz is a 5-star analyst with an average return of 11.0% and a 65.0% success rate. Lutz covers the Healthcare sector, focusing on stocks such as Guardian Pharmacy Services, Inc. Class A, Definitive Healthcare Corp, and Hims & Hers Health. ;'>

Currently, the analyst consensus on Cencora is a Strong Buy with an average price target of $346.00, a 25.5% upside from current levels. In a report issued on June 16, TipRanks – Google also downgraded the stock to Hold with a $308.00 price target.

See the top stocks recommended by analysts >>

UnitedHealth (UNH)

Bank of America Securities analyst Michael Craig Jones reiterated a Buy rating on UnitedHealth today and set a price target of $475.00. The company’s shares closed last Tuesday at $409.25.

According to TipRanks.com, Jones is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -24.3% and a 47.4% success rate. Jones covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Astrana Health, and Agilon Health. ;'>

UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $407.23, representing a -0.6% downside. In a report issued on June 9, Bernstein also assigned a Buy rating to the stock with a $492.00 price target.

Humana (HUM)

In a report released today, Kevin Fischbeck from Bank of America Securities reiterated a Hold rating on Humana, with a price target of $380.00. The company’s shares closed last Tuesday at $359.13.

According to TipRanks.com, Fischbeck is a 2-star analyst with an average return of 0.0% and a 58.1% success rate. Fischbeck covers the Healthcare sector, focusing on stocks such as Ardent Health Partners, Inc., Molina Healthcare, and Universal Health. ;'>

Humana has an analyst consensus of Hold, with a price target consensus of $294.56, a -18.6% downside from current levels. In a report issued on June 10, TipRanks – OpenAI also downgraded the stock to Hold with a $379.00 price target.

Read More on COR:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).